Motif Bio (MTFB) Share Price, News & Analysis

Company Overview

Motif Bio plc does not have any significant operations. It intends to identify a reverse takeover or other strategic transaction. Previously, the company was engaged in developing and commercializing pharmaceutical formulations. Motif Bio plc was incorporated in 2014 and is based in New York, New York.

Key Stats

• Today's Range: 0.50 to 0.50
• 50-Day Range: 0.50 to 0.50
• 52-Week Range: 0.03 to 3.20
• Volume: N/A
• Average Volume: 33.38 million shs
• Market Capitalization: £3.27 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

MTFB Stock Analysis - Frequently Asked Questions

How have MTFB shares performed this year?

Motif Bio's stock was trading at GBX 0.50 at the start of the year. Since then, MTFB stock has increased by 0.0% and is now trading at GBX 0.50.
View the best growth stocks for 2024 here.

How do I buy shares of Motif Bio?

Shares of MTFB stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What other stocks do shareholders of Motif Bio own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Motif Bio investors own include Hawkins (HWKN), Xtrackers California Municipal Bond ETF (CA), Sirius Minerals (SXX), Egdon Resources (EDR), BlackRock (BLK), Endologix (ELGX) and Global Blood Therapeutics (GBT).

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Current Symbol: LON:MTFB
• CUSIP: N/A
• CIK: N/A
• Web: www.motifbio.com
• Phone: 609-608-0032
• Fax: N/A
• Employees: 6
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 4.39
• Quick Ratio: 3.36

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: GBX 15.29 per share
• Price / Cash Flow: 0.03
• Book Value: GBX 15.50 per share
• Price / Book: 0.03

Miscellaneous

• Outstanding Shares: 654,991,000
• Free Float: N/A
• Market Cap: £3.27 million
• Optionable: Not Optionable
• Beta: N/A